If no Ann by 29 March shareholders may be running for the hills and a few cheap shares to be dumped by disillusioned sub-underwriters. Could be worth the wait..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025